Kurma Partners

Kurma Partners, established in 2009, is a Paris-based private equity and venture capital firm specializing in early-stage investments in healthcare and biotechnology sectors across Europe. The company focuses on financing innovation from pre-creation to development capital, supporting therapeutic and medical innovations, and collaborating with leading research institutes and hospitals. Kurma Partners manages several funds, including Kurma Biofund I, II, and Kurma Diagnostics, making it a significant player in European healthcare financing.

Laura Achach

Associate

Benjamin Belot

Partner

Hadrien Bouchez

Associate

Sylvain Cascarino

CFO and Partner

Florence de Coorebyter

Analyst

Maÿlis Deschamps

Analyst

Alain Horvais

Partner

Philippe Peltier

Partner

Ségolène Perin

Analyst

Katrien Swerts

Partner, AgrifoodTech

Past deals in Music Streaming

Poppins

Venture Round in 2025
Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.

Poppins

Venture Round in 2023
Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.

Poppins

Seed Round in 2021
Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.